Bharat Biotech begins export of Covaxin
By IANS | Published: November 29, 2021 02:45 PM2021-11-29T14:45:03+5:302021-11-29T14:55:07+5:30
Hyderabad, Nov 29 Bharat Biotech on Monday announced that it has commenced export of Covid-19 vaccine Covaxin. Long ...
Hyderabad, Nov 29 Bharat Biotech on Monday announced that it has commenced export of Covid-19 vaccine Covaxin.
Long Pending export orders have been executed during November, to be further expanded during the following months, the Hyderabad-based company said in a statement.
With the number of countries that have granted emergency use approvals for Covaxin increasing, exports to additional countries will also commence from December, it said.
The vaccine maker thanked the Government of India for approving exports. Covaxin will now become an integral part of the global fight against this pandemic, it added.
The company earlier said it was poised to achieve its goal of an annual capacity of about one billion doses of Covaxin by the end of 2021.
Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editorOpen in app